-
Adventure travel and ecotourism has become a huge industry, and certain destinations are becoming ever more popular. Current estimates suggest that more than 80,000 people travel annually to Nepal alone to trek.
-
This report updates the 2007 recommendations by the CDC Advisory Committee on Immunization Practices (ACIP) with regard to the use of influenza vaccine and antiviral agents.
-
There is a broad differential diagnosis for eosinophilia, defined as an absolute eosinophil count of > 500 cells/µl, yet cases due to helminthic disease probably occur more often in routine travelers than in the general population. There is a high index of suspicion concerning potential eosinophilia in immigrants and refugees.
-
A Brooklyn, NY, resident presented in early june with a one-week history of fever, headaches, left-sided pleuritic chest pain, and a pleural effusion.
-
Lourdes has been an important Catholic pilgrimage site for the elderly and infirm since 1858. This year marks the 150th anniversary of the apparition known as the "Lady of Lourdes," which was observed on multiple occasions that year by a 14-year-old peasant girl out searching for firewood.
-
-
Single nucleotide polymorphisms were examined within TLR2, TLR3, TLR4, and TLR9 in a population of 336 HSCT recipients and their unrelated donors. Using multivariate Cox regression analysis, two donor TLR4 haplotypes were found to be associated with increased risk of developing invasive aspergillosis in the HSCT recipients.
-
In the issue: 5-á reductase inhibitors and hip fracture in men; the effects of drug-reimbursement policy on outcomes; new guidelines for type 2 diabetes; beta-blocker-associated brady-cardia is linked to CVD events; FDA Updates.
-
-
The dramatic reduction in in-stent restenosis (ISR) afforded by drug-eluting stents (DES) led to their widespread use throughout the world. Subsequently, more patients and lesions could be treated percutaneously with less thought about ISR. With the advent of a more widespread adoption of percutaneous coronary intervention, registry data began suggesting an increased risk of late and very late stent thrombosis with DES compared to bare-metal stents (BMS).
